UA49171U - method for radiation therapy of metastasises into the brain at non-small cell lung cancer - Google Patents

method for radiation therapy of metastasises into the brain at non-small cell lung cancer

Info

Publication number
UA49171U
UA49171U UAU200909456U UAU200909456U UA49171U UA 49171 U UA49171 U UA 49171U UA U200909456 U UAU200909456 U UA U200909456U UA U200909456 U UAU200909456 U UA U200909456U UA 49171 U UA49171 U UA 49171U
Authority
UA
Ukraine
Prior art keywords
radiation therapy
pea
irradiation
stage
metastasises
Prior art date
Application number
UAU200909456U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Виктор Петрович Старенький
Наталья Андреевна Митряева
Оксана Николаевна Тарасова
Татьяна Станиславовна Бакай
Original Assignee
Государственное Учреждение "Институт Медицинской Радиологии Им. С.П. Григорьева Амн Украины"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Учреждение "Институт Медицинской Радиологии Им. С.П. Григорьева Амн Украины" filed Critical Государственное Учреждение "Институт Медицинской Радиологии Им. С.П. Григорьева Амн Украины"
Priority to UAU200909456U priority Critical patent/UA49171U/en
Publication of UA49171U publication Critical patent/UA49171U/en

Links

Landscapes

  • Radiation-Therapy Devices (AREA)

Abstract

A method for radiation therapy of metastasises into the brain at non-small cell lung cancer by irradiation of the lesion center with simultaneous chemomodification. The irradiation is carried out in two stages on two weeks each stage, at the first stage the radiation therapy is carried out in the classical mode 2 Gr x 5 fractions per week up to SOD 30 Gr on the background of chemomodification with Lomustine. The mode of the irradiation at the second stage is selected by means of an oncomarker of cancer and antigene (PEA) which level is determined in blood of the patient prior to the starting of irradiation (PEA) and in two weeks after starting of irradiation (PEA) with the subsequent determination of factor of the relation K=PEA/PEA, on which value a mode of radiation therapy at the second stage is made.
UAU200909456U 2009-09-14 2009-09-14 method for radiation therapy of metastasises into the brain at non-small cell lung cancer UA49171U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU200909456U UA49171U (en) 2009-09-14 2009-09-14 method for radiation therapy of metastasises into the brain at non-small cell lung cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU200909456U UA49171U (en) 2009-09-14 2009-09-14 method for radiation therapy of metastasises into the brain at non-small cell lung cancer

Publications (1)

Publication Number Publication Date
UA49171U true UA49171U (en) 2010-04-26

Family

ID=50689873

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU200909456U UA49171U (en) 2009-09-14 2009-09-14 method for radiation therapy of metastasises into the brain at non-small cell lung cancer

Country Status (1)

Country Link
UA (1) UA49171U (en)

Similar Documents

Publication Publication Date Title
EP2465923A3 (en) Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
MX2011013452A (en) Exosome based treatment of cancer.
WO2011112953A3 (en) Use of erbb3 inhibitors in the treatment of triple negative and basal-like breast cancers
MX342995B (en) Methods of generating natural killer cells.
WO2004074457A3 (en) Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
WO2010025321A3 (en) Method for treating multiple sclerosis patients with anti-il2r antibodies
EP4410367A3 (en) Systems for shuttle mode radiation delivery
EP2480565A4 (en) Peptidomimetic macrocycles
SG10201803845SA (en) Pyrazole derivatives as modulators of calcium release -activated calcium channel
WO2008039874A3 (en) Cancer stem cell antigen vaccines and methods
EP2068929A4 (en) Method for detecting and treating skin disorders
WO2005112546A3 (en) Mucinous glycoprotein (muc-1) vaccine
MX2012004522A (en) Treatment using reprogrammed mature adult cells.
MX2023003296A (en) Generating atrial and ventricular cardiomyocyte lineages from human pluripotent stem cells.
WO2014183033A3 (en) G-csf for use in treating or preventing a disease associated with aging in a patient, for administration with a stem-cell containing composition and/or an electromagnetic signal
PL1778833T3 (en) Methods of using regenerative cells to promote wound healing
ATE482720T1 (en) METHOD FOR PRODUCING TEMPERATURE-INDUCED TUMOR CELL LYSATES FOR USE AS IMMUNOGENIC COMPOUNDS
UA49171U (en) method for radiation therapy of metastasises into the brain at non-small cell lung cancer
MX2021011529A (en) Chiauranib for treatment of small cell lung cancer.
TW201144806A (en) Pdia4, target of cytopiloyne derivatives, for tumor diagnosis and treatment
WO2012118969A3 (en) Method of selecting cancer patients for anti-angiogenesis therapy in combination with chemotherapy
MY160857A (en) A cancer vaccine
WO2006014162A3 (en) Methods of using regenerative cells in the treatment of renal diseases and disorders
WO2008063837A3 (en) Dendritic cell tumor injection therapy and related vaccine
Forouzanfar The effects of low level laser therapy on the expression of collagen type I gene and proliferation of human gingival fibroblasts (Hgf3-Pi 53): in vitro study